LaFleur & Godfrey’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.33M | Sell |
8,234
-126
| -2% | -$70.7K | 0.51% | 50 |
|
|
2026
Q1 | $4.7M | Sell |
8,360
-121
| -1% | -$77.6K | 0.58% | 48 |
|
|
2025
Q4 | $5.74M | Sell |
8,481
-390
| -4% | -$266K | 0.69% | 46 |
|
|
2025
Q3 | $5.67M | Sell |
8,871
-945
| -10% | -$574K | 0.69% | 43 |
|
|
2025
Q2 | $5.26M | Sell |
9,816
-478
| -5% | -$229K | 0.66% | 45 |
|
|
2025
Q1 | $4.32M | Buy |
10,294
+465
| +5% | +$202K | 0.59% | 50 |
|
|
2024
Q4 | $4.06M | Sell |
9,829
-140
| -1% | -$61.4K | 0.56% | 50 |
|
|
2024
Q3 | $5.04M | Sell |
9,969
-328
| -3% | -$159K | 0.69% | 43 |
|
|
2024
Q2 | $5.02M | Sell |
10,297
-72
| -0.7% | -$36.1K | 0.74% | 43 |
|
|
2024
Q1 | $5.6M | Sell |
10,369
-625
| -6% | -$342K | 0.83% | 39 |
|
|
2023
Q4 | $6.1M | Sell |
10,994
-68
| -0.6% | -$31.9K | 0.91% | 36 |
|
|
2023
Q3 | $4.84M | Sell |
11,062
-81
| -0.7% | -$40.4K | 0.77% | 40 |
|
|
2023
Q2 | $5.6M | Buy |
11,143
+214
| +2% | +$103K | 0.84% | 39 |
|
|
2023
Q1 | $5.47M | Sell |
10,929
-154
| -1% | -$73.7K | 0.9% | 35 |
|
|
2022
Q4 | $4.52M | Buy |
11,083
+120
| +1% | +$46.6K | 0.75% | 41 |
|
|
2022
Q3 | $3.57M | Buy |
10,963
+585
| +6% | +$215K | 0.64% | 47 |
|
|
2022
Q2 | $3.64M | Buy |
10,378
+9,068
| +692% | +$3.7M | 0.58% | 46 |
|
|
2022
Q1 | $717K | Sell |
1,310
-25
| -2% | -$13.2K | 0.1% | 92 |
|
|
2021
Q4 | $879K | Hold |
1,335
| – | – | 0.11% | 92 |
|
|
2021
Q3 | $830K | Sell |
1,335
-10
| -0.7% | -$6.72K | 0.11% | 95 |
|
|
2021
Q2 | $849K | Sell |
1,345
-20
| -1% | -$11K | 0.12% | 95 |
|
|
2021
Q1 | $668K | Hold |
1,365
| – | – | 0.13% | 74 |
|
|
2020
Q4 | $682K | Hold |
1,365
| – | – | 0.14% | 74 |
|
|
2020
Q3 | $537K | Hold |
1,365
| – | – | 0.12% | 81 |
|
|
2020
Q2 | $451K | Hold |
1,365
| – | – | 0.12% | 60 |
|
|
2020
Q1 | $331K | Hold |
1,365
| – | – | 0.1% | 60 |
|
|
2019
Q4 | $356K | Hold |
1,365
| – | – | 0.08% | 63 |
|
|
2019
Q3 | $371K | Hold |
1,365
| – | – | 0.09% | 61 |
|
|
2019
Q2 | $376K | Hold |
1,365
| – | – | 0.09% | 60 |
|
|
2019
Q1 | $305K | Hold |
1,365
| – | – | 0.08% | 58 |
|
|
2018
Q4 | $254K | Hold |
1,365
| – | – | 0.07% | 60 |
|
|
2018
Q3 | $341K | Buy |
+1,365
| New | +$331K | 0.08% | 58 |
|
|
2018
Q2 | – | Sell |
-1,365
| Closed | -$261K | – | 63 |
|
|
2018
Q1 | $261K | Sell |
1,365
-1,350
| -50% | -$249K | 0.07% | 59 |
|
|
2017
Q4 | $425K | Hold |
2,715
| – | – | 0.1% | 62 |
|
|
2017
Q3 | $422K | Sell |
2,715
-500
| -16% | -$79.1K | 0.11% | 62 |
|
|
2017
Q2 | $519K | Sell |
3,215
-50
| -2% | -$8.12K | 0.14% | 62 |
|
|
2017
Q1 | $505K | Sell |
3,265
-4,655
| -59% | -$642K | 0.14% | 61 |
|
|
2016
Q4 | $929K | Sell |
7,920
-800
| -9% | -$91.3K | 0.26% | 57 |
|
|
2016
Q3 | $983K | Sell |
8,720
-1,305
| -13% | -$138K | 0.28% | 53 |
|
|
2016
Q2 | $931K | Sell |
10,025
-8,175
| -45% | -$702K | 0.28% | 56 |
|
|
2016
Q1 | $1.43M | Sell |
18,200
-67,510
| -79% | -$4.86M | 0.43% | 50 |
|
|
2015
Q4 | $6.25M | Buy |
85,710
+9,615
| +13% | +$686K | 1.85% | 17 |
|
|
2015
Q3 | $5.65M | Buy |
+76,095
| New | +$5.45M | 1.69% | 17 |
|
Other funds holding IDXX
LaFleur & Godfrey's IDXX Position: Q2 2026 in Review
LaFleur & Godfrey reduced its Idexx Laboratories (IDXX) stake by 1.5% in Q2 2026, selling an estimated $70.7K and leaving 8,234 shares worth $4.33M. The position accounts for 0.51% of the portfolio, ranked #50.
LaFleur & Godfrey first reported a position in IDXX in Q3 2015 and has held it in 43 quarters since. The position peaked at $6.25M in Q4 2015. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- LaFleur & Godfrey held 8,234 shares of Idexx Laboratories worth $4.33M as of Q2 2026.
- LaFleur & Godfrey sold 126 Idexx Laboratories shares in Q2 2026, an estimated $70.7K.
- Idexx Laboratories made up 0.51% of LaFleur & Godfrey's portfolio in Q2 2026, its #50 holding.
- LaFleur & Godfrey first reported a position in Idexx Laboratories in Q3 2015 and has held it in 43 quarters since.
- LaFleur & Godfrey's Idexx Laboratories position peaked at $6.25M in Q4 2015.
- 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on LaFleur & Godfrey's 13F filing for Q2 2026, filed 15 Jul 2026.